Cormorant Asset Management, LP
SEC insider (Form 3/4/5 filer). CIK 0001583977. Insider at BRIGHT MINDS BIOSCIENCES INC. (DRUG) and 5 other issuers. 27 reported Form 4/5 transactions since Sep 2024; latest on Apr 28, 2026. Located in BOSTON, MA.
Companies Cormorant Asset Management, LP has filed insider reports for
- BRIGHT MINDS BIOSCIENCES INC. (DRUG)
- Corbus Pharmaceuticals Holdings, Inc. (CRBP): 10% Owner
- EyePoint, Inc. (EYPT)
- OnKure Therapeutics, Inc. (OKUR): 10% Owner
- Aardvark Therapeutics, Inc. (AARD): 10% Owner
- BioAge Labs, Inc. (BIOA)
Cormorant Asset Management, LP
CIK: 0001583977
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Apr 28, 2026DRUG
BRIGHT MINDS BIOSCIENCES INC.
SaleIndirect109.3K shares at avg. $89.50$9.8M - Dec 11, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
SaleIndirect30K shares at avg. $11.46$344K - Dec 4, 2025EYPT
EyePoint, Inc.
SaleIndirect60K shares at avg. $15.70$942K - May 15, 2025OKUR
OnKure Therapeutics, Inc.
SaleIndirect1.8M shares at avg. $1.85$3.4M - May 12, 2025OKUR
OnKure Therapeutics, Inc.
SaleIndirect24.3K shares at avg. $1.99$48K - Feb 14, 2025AARD
Aardvark Therapeutics, Inc.
ConversionIndirect800.2K shares- - Feb 14, 2025AARD
Aardvark Therapeutics, Inc.
PurchaseIndirect187.5K shares at avg. $16.00$3.0M - Nov 4, 2024DRUG
BRIGHT MINDS BIOSCIENCES INC.
PurchaseIndirect184.3K shares at avg. $21.70$4.0M - Oct 16, 2024DRUG
BRIGHT MINDS BIOSCIENCES INC.
PurchaseIndirect39.7K shares at avg. $23.21$923K - Oct 16, 2024DRUG
BRIGHT MINDS BIOSCIENCES INC.
PurchaseIndirect3.1K shares at avg. $25.22$78K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 28, 2026 |  DRUG BRIGHT MINDS BIOSCIENCES INC. | Sale | 109,331 | $89.50 | $9,785,125 | Indirect |
| Dec 11, 2025 |  CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 30,029 | $11.46 | $344,012 | Indirect |
| Dec 4, 2025 |  EYPT EyePoint, Inc. | Sale | 60,000 | $15.70 | $942,240 | Indirect |
| May 15, 2025 |  OKUR OnKure Therapeutics, Inc. | Sale | 1,813,439 | $1.85 | $3,363,023 | Indirect |
| May 12, 2025 | OKUR OnKure Therapeutics, Inc. | Sale | 24,300 | $1.99 | $48,236 | Indirect |
| Feb 14, 2025 |  AARD Aardvark Therapeutics, Inc. | Conversion | 800,189 | - | - | Indirect |
| Feb 14, 2025 | AARD Aardvark Therapeutics, Inc. | Purchase | 187,500 | $16.00 | $3,000,000 | Indirect |
| Nov 4, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | Purchase | 184,331 | $21.70 | $3,999,983 | Indirect |
| Oct 16, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | Purchase | 39,743 | $23.21 | $922,634 | Indirect |
| Oct 16, 2024 | DRUG BRIGHT MINDS BIOSCIENCES INC. | Purchase | 3,107 | $25.22 | $78,365 | Indirect |
1-10 of 27 transactions